🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-01
Trial ID
NCT04337658
Treatments Being Tested
This is a phase III clinical trial to evaluate the efficacy and safety of X...
Status
Active Not Recruiting
Location
Chinese Academy of Medical Science
Start Date
2021-11-16
Trial ID
NCT05077449
Treatments Being Tested
This study will assess the relationship between fulvestrant dose and effica...
Status
Completed
Location
Research Site
Start Date
2006-05-30
Trial ID
NCT00313170
Treatments Being Tested
This is a randomized trial for patients with metastatic hormone receptor (H...
Status
Completed
Location
University of Alabama at Birmingham (UAB)
Start Date
2016-03
Trial ID
NCT02632045
Treatments Being Tested
Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule in...
Status
Recruiting
Location
Florida Cancer Specialists
Start Date
2023-03-28
Trial ID
NCT05735080
Treatments Being Tested
Fulvestrant 500mg in Patients With Advanced Breast Cancer...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2017-10-11
Trial ID
NCT02909361
Treatments Being Tested
This is a phase 2 single-arm, open-label determining efficacy of Neo-adjuva...
Status
Terminated
Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Start Date
2020-07-23
Trial ID
NCT04305236
Treatments Being Tested
This study is to evaluate the safety, pharmacokinetics, and preliminary ant...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-01-02
Trial ID
NCT06950086
Treatments Being Tested
This single arm phase II study proposes to evaluate the efficacy and safety...
Status
Active Not Recruiting
Location
OU Health Stephenson Cancer Center
Start Date
2024-12-26
Trial ID
NCT06494150
Treatments Being Tested